3 Australian Growth Stocks With Earnings Growth Over 12%

Energy and raw material costs are back in the spotlight after the World Bank warned that global commodity prices could be 23% higher in 2026. For Australian growth stocks where founders and executives still own large stakes, pricing power and aligned management become especially important. This article highlights three fast growing, high insider ownership companies from our screener that could merit a place on your watchlist.

The three stocks highlighted here offer a compelling starting point if you want exposure to fast growing businesses where insiders have meaningful skin in the game. However, if you want the strongest names, these 26 high growth high conviction stocks are the top of the list.

Regis Healthcare (ASX:REG)

Regis Healthcare runs residential aged care homes and home care services across Australia, with its growth closely tied to expanding and upgrading higher acuity facilities that fit the Fast Growing Stocks With High Insider Ownership theme. The group generated about A$1.4b from aged care and related services and has a market value near A$1.4b.

Regis Healthcare matters here because its business model leans on expanding aged care capacity and premium services, so the way it earns and retains resident funding becomes central to the growth story.

"While the new 2% RAD retention framework and higher advertised room prices support a growing capital like earnings stream, any change in government policy settings around RADs or retention rates would directly affect this contribution to EBITDA and long term earnings."

What ultimately happens to margins and cash generation hangs on one pressure point investors cannot afford to treat as a minor assumption.

That pressure point is exactly why it is worth reading the full narrative for Regis Healthcare to see how Regis Healthcare could turn policy risk into an engine for accelerating capital returns.

Telix Pharmaceuticals (ASX:TLX)

Telix Pharmaceuticals focuses on precision radiopharmaceuticals for cancer imaging and treatment, which fits the Fast Growing Stocks With High Insider Ownership theme through late-stage products that management is actively pushing toward broader commercial use.

Telix Pharmaceuticals generates about US$705 million from Precision Medicine and US$277 million from Manufacturing Solutions, with smaller adjustments between segments, and has a market value near A$4.4b.

Telix Pharmaceuticals matters to this theme because its pipeline of late-stage radiopharmaceuticals gives it multiple shots at scaling clinically proven products into much bigger markets.

"Their primary revenue generating imaging agents: 'Illuccix' and 'Gozellix' are utilised in 23+ countries worldwide, including key markets such as the U.S, Europe, China and Japan, with revenue figures of $803.8m (USD) in the 2025 Financial Year."

The outcome of a single pressure point on future trial results will determine how far that growth story can develop.

That single pressure point is the reason to read the full narrative for Telix Pharmaceuticals, which explains how Telix Pharmaceuticals could turn trial risk into accelerating commercial momentum.

Codan (ASX:CDA)

Codan blends communications hardware with its Metal Detection arm, where gold-mining and hobbyist detectors align most directly with the Fast Growing Stocks With High Insider Ownership theme. The company generates about A$506 million from Communications and A$362 million from Metal Detection, supported by a roughly A$10.8b market cap.

For growth-focused investors, Codan matters because its metal detection business taps into small-scale gold mining and hobbyist demand. Its communications arm also links into defence and public safety projects that management describes with clear confidence.

"While Codan reports very strong demand for unmanned systems and a Communications order book of A$380m, management also highlights low order visibility from conflict regions."

What happens to growth and margins now largely hinges on how one less obvious dependency inside that communications pipeline ultimately plays out.

That hinge point is exactly why reading the full narrative for Codan can clarify whether Codan's communications pipeline risk is masking a stronger long term earnings engine.

Seeking Alternatives Before The Crowd?

Fresh opportunities move fast. Breakout ideas gain momentum, quiet winners stop flying under the radar, and solid prospects get caught once data drops. Scan new candidates and act now.

• Spot cash generative businesses that still trade like afterthoughts by checking the 2 high quality undervalued stocks before the wider market catches on.
• Track income workhorses built around sturdy payouts and balance sheets by reviewing the 4 dividend fortresses while yields remain appealing.
• Back structural shifts in automation and efficiency by scanning the 94 robotics and automation stocks for operators building revenue from real-world deployments.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com